Our data, comprising 1469 CRC patients, reveal a significant association of CD10 expression with earlier tumour stages, with the highest proportion of CD10 positive tumours in the pT1 stage and the highest frequency of strong expression in the pT2 stage. This evidence concerns the gene MME and colorectal carcinoma.